A variable combination of interstitial lung disease, myopathy, fever, joint involvement, and mechanic’s hands characterize this systemic autoimmune syndrome
Search results for: antinuclear antibody
ACR/ARHP Annual Meeting 2012: Serum Antibodies Offer Useful Clinical Insights into Systemic Sclerosis
Understanding the role of autoantibodies in systemic sclerosis (SSc) may help predict the course of the disease and guide clinical trials
Tips for Myositis Management
Differentiating between subgroups of myositis is a diagnostic challenge for physicians, but using some guiding principles can be helpful,
Rheumatology Chooses Wisely
ACR identifies five practices, therapies, or procedures physicians and patients should question
What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)
Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
Fellow’s Forum Case Report: True Vasculitis or Vasculitis Mimic?
Rheumatologists face the emerging picture of cocaine and levamisole-associated vasculopathy in clinical practice
Ethics Forum: The Ethical Side of End-of-Life Decisions
The role of the consulting physicians in the ICU, the concept of medical futility, and the management of complex patients when the goals of care may be changing.
Inflammatory Myopathies in Children
Treatment options and recent research for juvenile dermatomyositis.
Sjögren’s Syndrome Moves into the Spotlight
Between 400,000 and 3.1 million adults are affected by Sjögren’s syndrome, and the disease is often challenging to identify.
Three Giants of Immunology at USC
Prejudice, and how I became a rheumatologist.
- « Previous Page
- 1
- …
- 4
- 5
- 6
- 7
- 8
- …
- 10
- Next Page »